These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 30986539)

  • 1. Methyl aminolevulinate-based photodynamic therapy of Bowen´s disease: Observational study of 21 lesions.
    Gómez C; Cobos M; Alberdi E
    Photodiagnosis Photodyn Ther; 2019 Jun; 26():295-299. PubMed ID: 30986539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interventions for cutaneous Bowen's disease.
    Bath-Hextall FJ; Matin RN; Wilkinson D; Leonardi-Bee J
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD007281. PubMed ID: 23794286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photodynamic therapy in the treatment of extensive Bowen's disease.
    López N; Meyer-Gonzalez T; Herrera-Acosta E; Bosch R; Castillo R; Herrera E
    J Dermatolog Treat; 2012 Dec; 23(6):428-30. PubMed ID: 21787214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ablative fractional laser-assisted photodynamic therapy provides superior long-term efficacy compared with standard methyl aminolevulinate photodynamic therapy for lower extremity Bowen disease.
    Kim HJ; Song KH
    J Am Acad Dermatol; 2018 Nov; 79(5):860-868. PubMed ID: 29857012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylaminolaevulinate-based photodynamic therapy of Bowen's disease and squamous cell carcinoma.
    Calzavara-Pinton PG; Venturini M; Sala R; Capezzera R; Parrinello G; Specchia C; Zane C
    Br J Dermatol; 2008 Jul; 159(1):137-44. PubMed ID: 18489606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The France-PDT study: a national prospective observational cohort survey on the use of methyl-aminolevulinate photodynamic therapy in France, with up to 6-month follow-up.
    Farhi D; Bedane C; Savary J; Basset-Seguin N
    Eur J Dermatol; 2013; 23(1):68-76. PubMed ID: 23400280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methyl aminolevulinate: actinic keratoses and Bowen's disease.
    Morton CA
    Dermatol Clin; 2007 Jan; 25(1):81-7. PubMed ID: 17126745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methyl-aminolevulinate photodynamic therapy for the treatment of actinic keratoses and non-melanoma skin cancers: a retrospective analysis of response in 462 patients.
    Fai D; Arpaia N; Romano I; Vestita M; Cassano N; Vena GA
    G Ital Dermatol Venereol; 2009 Jun; 144(3):281-5. PubMed ID: 19528909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial comparing methyl aminolaevulinate photodynamic therapy with and without Er:YAG ablative fractional laser treatment in Asian patients with lower extremity Bowen disease: results from a 12-month follow-up.
    Ko DY; Kim KH; Song KH
    Br J Dermatol; 2014 Jan; 170(1):165-72. PubMed ID: 24102369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Bowen's disease with photodynamic therapy. Observational study in 171 patients with 5-aminolaevulinic acid (BF-200 ALA) and methyl aminolaevulinate (MAL).
    Alique-García S; Alique D; Company-Quiroga J; Sánchez A; Núñez AH; Borbujo J
    Photodiagnosis Photodyn Ther; 2019 Dec; 28():192-194. PubMed ID: 31398515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cost analysis of photodynamic therapy with methyl aminolevulinate and imiquimod compared with conventional surgery for the treatment of superficial basal cell carcinoma and Bowen's disease of the lower extremities.
    Aguilar M; de Troya M; Martin L; Benítez N; González M
    J Eur Acad Dermatol Venereol; 2010 Dec; 24(12):1431-6. PubMed ID: 20456549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methyl aminolevulinate-PDT for actinic keratoses and superficial nonmelanoma skin cancers.
    Ortiz-Policarpio B; Lui H
    Skin Therapy Lett; 2009; 14(6):1-3. PubMed ID: 19609473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term efficacy of photodynamic therapy with methyl aminolevulinate in treating Bowen's disease in clinical practice: A retrospective cohort study (2006-2017).
    Aguilar-Bernier M; Rodríguez-Barón D; Rivas-Ruiz F; Segura-Palacios JM; de Troya Martín M
    Photodermatol Photoimmunol Photomed; 2019 Jul; 35(4):208-213. PubMed ID: 30690796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of photodynamic therapy with topical 5-aminolevulinic acid using intense pulsed light for Bowen's disease.
    Hasegawa T; Suga Y; Mizuno Y; Haruna K; Ogawa H; Ikeda S
    J Dermatol; 2010 Jul; 37(7):623-8. PubMed ID: 20629828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photodynamic therapy with epidermal ablation using fractional carbon-dioxide laser in the treatment of Bowen's disease: A case series.
    Sung JM; Kim YC
    Photodiagnosis Photodyn Ther; 2017 Sep; 19():84-85. PubMed ID: 28457851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of metil aminolevulinate (MAL)-PDT in difficult-to-treat cutaneous Bowen's disease.
    Cavicchini S; Serini SM; Fiorani R; Girgenti V; Ghislanzoni M; Sala F
    Int J Dermatol; 2011 Aug; 50(8):1002-5. PubMed ID: 21781078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical excision versus topical 5% 5-fluorouracil and photodynamic therapy in treatment of Bowen's disease: A multicenter randomized controlled trial.
    Ahmady S; Nelemans PJ; Kelleners-Smeets NWJ; Arits AHMM; de Rooij MJM; Kessels JPHM; Essers BAB; Mosterd K
    J Am Acad Dermatol; 2024 Jan; 90(1):58-65. PubMed ID: 37666424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photodynamic therapy for subungual Bowen's disease.
    Tan B; Sinclair R; Foley P
    Australas J Dermatol; 2004 Aug; 45(3):172-4. PubMed ID: 15250896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term recurrence of nonmelanoma skin cancer after topical methylaminolevulinate photodynamic therapy in a dermato-oncology department.
    Cabete J; Rafael M; Cravo M; Moura C; Sachse F; Pecegueiro M
    An Bras Dermatol; 2015; 90(6):846-50. PubMed ID: 26734866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of photodynamic therapy in Bowen's disease: an observational and descriptive study in 51 lesions.
    Truchuelo M; Fernández-Guarino M; Fleta B; Alcántara J; Jaén P
    J Eur Acad Dermatol Venereol; 2012 Jul; 26(7):868-74. PubMed ID: 21740466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.